A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Squamous Cell Carcinoma
Intervention:   Drug: BB-401
Sponsor:   Benitec BioPharma Ltd
Not yet recruiting

http://ift.tt/2Et0eNa